- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05971797
Rational-emotional Behavioral Therapy (REBT) in Patients With Osteoarthritis and Concomitant Diseases Before Arthroplasty (REBT)
August 2, 2023 updated by: Emelianov Vladimir, Federal State Budgetary Organization, Federal Center for Traumatology, Orthopedics and Arthroplasty
Rational-emotional Behavioral Therapy in Patients With Osteoarthritis and Concomitant Diseases Before Knee or Hip Arthroplasty
The objective of this study was evaluation of the effectiveness of REBT on the emotional state of orthopedic patients with comorbidities before and after arthroplasty.
Study Overview
Detailed Description
The studies assessed depression or anxiety in orthopedic patients by using Spielberger State-Trait Anxiety Inventory (STAI) and Hospital Anxiety and Depression Scale (HADS) before and after athroplasty.
The comorbid background studied.
The orthopedic patients with comorbidities were divided into several groups: arterial hypertension, chronic pyelonephritis , varicose veins, cardiovascular disease and atherosclerosis, diabetes mellitus, infection diseases, gastrointestinal diseases, obesity, neurological disorder, cerebrovascular accident, iron deficiency anemia, chronic bronchitis, hyperthyroidism, cardiac arrhythmia, other diseases.
Patients with high levels of anxiety and depression underwent Rational Emotive Behavior Therapy before surgery.
Patients without comorbidities and patients with comorbidities but without exposure considered as a control.
Study Type
Interventional
Enrollment (Actual)
95
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Chuvashia
-
Cheboksary, Chuvashia, Russian Federation, 429500
- Federal Center for Traumatology, Orthopedics and Endoprosthetics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients enrolled for the primary knee or hip arthroplasty (M15.0, M16, M17) before operation.
Exclusion Criteria:
- Other types of psychiatric pathology
- Reluctance to undergo psychological correction
- Failure to pass pre-test
- Ongoing follow-up with a psychologist or psychiatrist
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Comorbidities control
Upon admission to the hospital for surgery to replace large joints (knee or hip joints) and diagnosis with osteoarthritis of the knee or hip joint (M15.0,
M16, M17), patients with comorbidities underwent 20-minute PC.
During PC, their levels of depression (F32.0,
F32.1 or F32.9) and anxiety (F41.0,
F41.1, F41.3, F41.8 or F41.9) were assessed using the STAI and HADS questionnaires.
In the first control group, patients with identified increased levels of depression or anxiety did not receive REBT therapy.
The level of anxiety and depression was reassessed after the surgery.
|
|
|
Active Comparator: No comorbidities
Upon admission to the hospital for surgery to replace large joints (knee or hip joints) and diagnosis with osteoarthritis of the knee or hip joint (M15.0,
M16, M17), patients without comorbidities underwent 20-minute PC session.
During PC the levels of depression (F32.0,
F32.1 or F32.9) and anxiety (F41.0,
F41.1, F41.3, F41.8 or F41.9) were assessed using the the STAI and HADS questionnaires.
In the second control group, patients with identified increased levels of depression or anxiety underwent a session of rational-emotional-behavioral therapy, which aimed to modify incorrect thinking patterns.
The level of anxiety and depression was reassessed after the surgery.
|
During REBT in patients with osteoarthritis and concomitant diseases with diagnosed depression or anxiety before arthroplasty the patients learn how to manage their irrational or unhealthy emotions, thoughts, and behaviors.
|
|
Experimental: Comorbidities
Upon admission to the hospital for surgery to replace large joints (knee or hip joints) and diagnosis with osteoarthritis of the knee or hip joint (M15.0,
M16, M17), patients with comorbidities underwent 20-minute psychological counseling (PC) session.
During PC the levels of depression (F32.0,
F32.1 or F32.9) and anxiety (F41.0,
F41.1, F41.3, F41.8 or F41.9) were assessed using the STAI and HADS questionnaires.
In the experimental group, patients with identified increased levels of depression or anxiety underwent a session of rational-emotional-behavioral therapy, which aimed to modify incorrect thinking patterns.
The level of anxiety and depression was reassessed after the surgery.
|
During REBT in patients with osteoarthritis and concomitant diseases with diagnosed depression or anxiety before arthroplasty the patients learn how to manage their irrational or unhealthy emotions, thoughts, and behaviors.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
STAI
Time Frame: 2 days after surgery
|
Each subscale uses a 4-point Likert scale with a range from 1 ("not at all" for S- or "almost never" for T-Anxiety) to 4 ("very much so" for S- and "almost always" for T-Anxiety).
Reverse scoring is used for anxiety-absent items (e.g., "I feel calm" or "I am happy"), and therefore, a higher score indicates more severe anxiety with a potential range from 20 to 80 for each subscale.
According to the developer scores of 20-39, 40-59, and 60-80 indicate low, moderate, and high anxiety, respectively.
Normative values are available in the manual.
|
2 days after surgery
|
|
HADS
Time Frame: 2 days after surgery
|
The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3).
with a range from 0 ("not at all") to 3 ("most of the time").
Reverse scoring is used for items with positive wording (e.g., "I still enjoy the things I used to enjoy").
The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21).
A score of 8-10 should be classified as a mild disorder, 11-15 as a moderate disorder, and 16 or more as a severe disorder.
|
2 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2020
Primary Completion (Actual)
January 1, 2021
Study Completion (Actual)
December 31, 2021
Study Registration Dates
First Submitted
July 5, 2023
First Submitted That Met QC Criteria
July 25, 2023
First Posted (Actual)
August 2, 2023
Study Record Updates
Last Update Posted (Actual)
August 3, 2023
Last Update Submitted That Met QC Criteria
August 2, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-9
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
Clinical Trials on REBT
-
Babes-Bolyai UniversityCompletedAnxiety Disorders | Generalized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic Disorder | Persistent Depressive DisorderRomania
-
Babes-Bolyai UniversityCompletedGeneralized Anxiety Disorder | Social Anxiety | Panic Disorder | Specific Phobia | Major Depression MildRomania
-
Babes-Bolyai UniversityCompletedPsychological Distress | Worry | Career Decision-making DifficultiesRomania
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Institut Català de la SalutRecruiting
-
Fundacio d'Investigacio en Atencio Primaria Jordi...CompletedDepression | Dysthymia | Ambulatory Health ServicesSpain